131 related articles for article (PubMed ID: 7870726)
1. [Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
Kunichan AD; Sokolova GB; Shapatava MN
Probl Tuberk; 1994; (5):40-3. PubMed ID: 7870726
[TBL] [Abstract][Full Text] [Related]
2. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Paramasivan CN; Herbert D; Prabhakar R
Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
[TBL] [Abstract][Full Text] [Related]
4. [Effects of isoniazid and rifampicin on cell elements of cultured intact pulmonary tissue from experimental animals].
Kunichan AD; Shapatava MN; Sokolova GB
Probl Tuberk; 1991; (2):9-12. PubMed ID: 1903533
[No Abstract] [Full Text] [Related]
5. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
6. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
[TBL] [Abstract][Full Text] [Related]
7. [Effect of levofloxacine on cell elements of the lung tissue and on the growth of drug resistant Mycobacteria tuberculosis].
Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD
Antibiot Khimioter; 2002; 47(6):12-7. PubMed ID: 12422642
[TBL] [Abstract][Full Text] [Related]
8. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
Hu Y; Coates AR; Mitchison DA
Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
[TBL] [Abstract][Full Text] [Related]
9. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA
Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.
Kubendiran G; Paramasivan CN; Sulochana S; Mitchison DA
J Chemother; 2006 Dec; 18(6):617-23. PubMed ID: 17267339
[TBL] [Abstract][Full Text] [Related]
12. A comparison of conventional and radiometric methods for the assessment of anti-tubercular activity of drugs against Mycobacterium tuberculosis in mice and macrophage models.
Jhamb SS; Singh RP; Singh PP
Indian J Tuberc; 2008 Apr; 55(2):70-6. PubMed ID: 18516822
[TBL] [Abstract][Full Text] [Related]
13. [The latest topics concerning pyrazinamide].
Kekkaku; 1985 Nov; 60(11):585-603. PubMed ID: 3937931
[No Abstract] [Full Text] [Related]
14. A whole blood bactericidal assay for tuberculosis.
Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
[TBL] [Abstract][Full Text] [Related]
15. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
Heifets L; Higgins M; Simon B
Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
[TBL] [Abstract][Full Text] [Related]
16. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
Nitti V; Ninni A; Natali P
Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
[No Abstract] [Full Text] [Related]
17. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
Karakousis PC; Williams EP; Bishai WR
J Antimicrob Chemother; 2008 Feb; 61(2):323-31. PubMed ID: 18156607
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
20. Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
